Literature DB >> 7846057

CTLA4 mediates antigen-specific apoptosis of human T cells.

J G Gribben1, G J Freeman, V A Boussiotis, P Rennert, C L Jellis, E Greenfield, M Barber, V A Restivo, X Ke, G S Gray.   

Abstract

The regulation of T cell-mediated immune responses requires a balance between amplification and generation of effector function and subsequent selective termination by clonal deletion. Although apoptosis of previously activated T cells can be induced by signaling of the tumor necrosis factor receptor family, these molecules do not appear to regulate T-cell clonal deletion in an antigen-specific fashion. We demonstrate that cross-linking of the inducible T-cell surface molecule CTLA4 can mediate apoptosis of previously activated human T lymphocytes. This function appears to be antigen-restricted, since a concomitant signal T-cell receptor signal is required. Regulation of this pathway may provide a novel therapeutic strategy to delete antigen-specific activated T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7846057      PMCID: PMC42710          DOI: 10.1073/pnas.92.3.811

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation.

Authors:  J A Hardin; D H Sherr; M DeMaria; P A Lopez
Journal:  J Immunol Methods       Date:  1992-09-18       Impact factor: 2.303

2.  Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.

Authors:  D E Staunton; A Gaur; P Y Chan; T A Springer
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

3.  Receptor-stimulated death pathway is opened by antigen in mature T cells.

Authors:  J H Russell; C L White; D Y Loh; P Meleedy-Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

4.  CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.

Authors:  P S Linsley; J Bradshaw; M Urnes; L Grosmaire; J A Ledbetter
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

5.  Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

Authors:  S Webb; C Morris; J Sprent
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

6.  The type B receptor for tumor necrosis factor-alpha mediates DNA fragmentation in HL-60 and U937 cells and differentiation in HL-60 cells.

Authors:  M S Greenblatt; L Elias
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

7.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Authors:  P S Linsley; W Brady; L Grosmaire; A Aruffo; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

8.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Authors:  S Yonehara; A Ishii; M Yonehara
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

9.  CTLA-4 is a second receptor for the B cell activation antigen B7.

Authors:  P S Linsley; W Brady; M Urnes; L S Grosmaire; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

10.  Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.

Authors:  P S Linsley; J L Greene; P Tan; J Bradshaw; J A Ledbetter; C Anasetti; N K Damle
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  68 in total

1.  CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

2.  Effect of Chronic Uremia on the Cell Surface Expression of B7 Family Costimulatory Molecules in an HLA-A2 Transgenic Mouse Model of Chronic Kidney Disease.

Authors:  Paul E Makidon; Douglas M Smith; Jeffery V Groom Ii; Zhengyi Cao; Jeffery J Landers; James R Baker
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

3.  Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

Authors:  Leila Ksiaa Cheikhrouhou; Yousr Lakhoua-Gorgi; Imen Sfar; Salwa Jendoubi-Ayed; Houda Aouadi; Mouna Makhlouf; Khaled Ayed; Taieb Ben Abdallah
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

Review 4.  Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution.

Authors:  Annabel Kuek; Brian L Hazleman; Andrew J K Ostör
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

5.  The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.

Authors:  C-O Jonson; M Hedman; M Karlsson Faresjö; R Casas; J Ilonen; J Ludvigsson; O Vaarala
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 6.  Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

7.  CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.

Authors:  Josef Kurtz; Forum Raval; Casey Vallot; Jayden Der; Megan Sykes
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

Review 8.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

9.  Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

Authors:  M K Racke; D E Scott; L Quigley; G S Gray; R Abe; C H June; P J Perrin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 10.  The role of B7 family molecules in hematologic malignancy.

Authors:  Paul Greaves; John G Gribben
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.